| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/27/2001 | US6207165 Polynucleotide formula against porcine reproductive and respiratory pathologies |
| 03/27/2001 | US6207162 AspS from Chlamydia trachomatis |
| 03/27/2001 | US6207161 Genetic engineering |
| 03/27/2001 | US6207160 aPL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies |
| 03/27/2001 | US6207159 Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus |
| 03/27/2001 | US6207158 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof |
| 03/27/2001 | US6207157 Conjugate vaccine for nontypeable Haemophilus influenzae |
| 03/27/2001 | US6207156 Specific antibodies and antibody fragments |
| 03/27/2001 | US6207153 Antigen binding polypeptide |
| 03/27/2001 | US6207152 Anticancer agent |
| 03/27/2001 | US6207147 Cancer immunotherapy using tumor cells combined with mixed lymphocytes |
| 03/27/2001 | CA2135200C Canine coronavirus s gene and uses therefor |
| 03/27/2001 | CA2125787C Detection of alzheimer's disease and other diseases using a photoaffinity labeling method |
| 03/27/2001 | CA2076540C Recombinant antibodies specific for tnf-.alpha. |
| 03/27/2001 | CA2065860C Inhibiting transforming growth factor .beta. to prevent accumulation of extracellular matrix |
| 03/27/2001 | CA2007499C Treatment methods and vaccines for stimulating an immune response |
| 03/23/2001 | CA2309372A1 Use of antibodies against the nef protein for decreasing the chemotaxis which is induced by retrovirus-infected astrocytes |
| 03/22/2001 | WO2001020033A1 Methods for selecting prostate cancer treatments and treating prostate cancer |
| 03/22/2001 | WO2001020026A2 POLYMORPHISMS IN THE HUMAN hPXR GENE AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 03/22/2001 | WO2001020025A2 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 03/22/2001 | WO2001020013A2 Viral replicons and viruses dependent on inducing agents |
| 03/22/2001 | WO2001019998A1 Novel detoxified mutants of escherichia coli heat-labile enterotoxin |
| 03/22/2001 | WO2001019997A2 Basb128 polypeptide and polynucleotide from moxarella catarrhalis |
| 03/22/2001 | WO2001019996A1 Moraxella catarrhalis antigen, corresponding gene and uses thereof |
| 03/22/2001 | WO2001019993A2 Virulence genes of m. marinum and m. tuberculosis |
| 03/22/2001 | WO2001019992A2 FACTOR IX/FACTOR IXa ANTIBODIES AND ANTIBODY DERIVATIV ES |
| 03/22/2001 | WO2001019974A2 Recombinant microorganisms |
| 03/22/2001 | WO2001019958A2 Stabilized soluble glycoprotein trimers |
| 03/22/2001 | WO2001019871A2 Delivery system for antidandruff agent |
| 03/22/2001 | WO2001019869A1 Dendritic cell membrane protein cire |
| 03/22/2001 | WO2001019862A2 Polypeptides from moraxella (branhamella) catarrhalis |
| 03/22/2001 | WO2001019861A2 Apo-2 receptor antibodies |
| 03/22/2001 | WO2001019860A2 Proteins associated with cell differentiation |
| 03/22/2001 | WO2001019856A2 Secreted human proteins, polynucleotides encoding them and methods of using the same |
| 03/22/2001 | WO2001019855A2 Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 03/22/2001 | WO2001019408A1 Nucleic acids encoding polyepitope polypeptides |
| 03/22/2001 | WO2001019398A1 Method for treatment of symptoms of central nervous system disorders |
| 03/22/2001 | WO2001019397A1 Methods and compositions utilizing rad51 |
| 03/22/2001 | WO2001019396A1 Therapies for chronic renal failure using one or more integrin antagonists |
| 03/22/2001 | WO2001019395A1 Acellular immunogenic compositions and acellular vaccine compositions against bacillus anthracis |
| 03/22/2001 | WO2001019373A2 Methods and compositions for modulating responsiveness to corticosteroids |
| 03/22/2001 | WO2001019335A2 Composition to be administered through mucous membrane |
| 03/22/2001 | WO2001009332A3 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof |
| 03/22/2001 | WO2000073323A3 Adam polynucleotides and polypeptides |
| 03/22/2001 | WO2000069255A8 Anti-inflammatory therapy for inflammatory mediated infection |
| 03/22/2001 | WO2000059943A3 MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN Mcm3, PROCESS FOR THEIR PRODUCTION, AND THEIR USE |
| 03/22/2001 | WO2000059538A3 Antigen-specific induction of peripheral immune tolerance |
| 03/22/2001 | WO2000055629A3 Methods of diagnosing and treating breast cancer |
| 03/22/2001 | WO2000045840A8 Compositions and methods for treating and preventing pathogenic bacterial infection based on the essential role of dna methylation in bacterial virulence |
| 03/22/2001 | WO2000029443A9 Contraceptive antibody vaccines |
| 03/22/2001 | WO1999058678A9 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 03/22/2001 | CA2386530A1 Viral replicons and viruses dependent on inducing agents |
| 03/22/2001 | CA2384987A1 Nucleic acids encoding polyepitope polypeptides |
| 03/22/2001 | CA2384920A1 Moraxella catarrhalis antigen, corresponding gene and uses thereof |
| 03/22/2001 | CA2384876A1 Composition to be administered through mucous membrane |
| 03/22/2001 | CA2384860A1 Recombinant eggs and gene cloning and expression vectors based on avian adenoviruses |
| 03/22/2001 | CA2384762A1 Apo-2 receptor antibodies |
| 03/22/2001 | CA2384749A1 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 03/22/2001 | CA2384733A1 Methods and compositions utilizing rad51 |
| 03/22/2001 | CA2384660A1 Factor ix/factor ixa antibodies and antibody derivatives |
| 03/22/2001 | CA2384324A1 Proteins associated with cell differentiation |
| 03/22/2001 | CA2384271A1 Stabilized soluble glycoprotein trimers |
| 03/22/2001 | CA2384246A1 Glucosamine and egg reducing inflammation |
| 03/22/2001 | CA2383360A1 Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 03/22/2001 | CA2383292A1 Basb128 polypeptide and polynucleotide from moxarella catarrhalis |
| 03/22/2001 | CA2383081A1 Polypeptides from moraxella (branhamella) catarrhalis |
| 03/22/2001 | CA2382067A1 Recombinant microorganisms |
| 03/22/2001 | CA2381066A1 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications |
| 03/22/2001 | CA2379541A1 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 03/22/2001 | CA2344155A1 Methods for selecting prostate cancer treatments and treating prostate cancer |
| 03/21/2001 | EP1084709A1 Oral recombinant lactobacilli vaccines |
| 03/21/2001 | EP1084705A2 Method for lowering blood glucose levels in mammals |
| 03/21/2001 | EP1084261A1 Recombinant venezuelan equine encephalitis virus vaccine |
| 03/21/2001 | EP1084255A1 Tankyrase, a trf1 binding protein |
| 03/21/2001 | EP1084253A1 Hiv virus mimotopes |
| 03/21/2001 | EP1084252A1 Nucleic acid vaccines for prevention of flavivirus infection |
| 03/21/2001 | EP1084251A2 Attenuated pestiviruses |
| 03/21/2001 | EP1084246A2 Biological material for preparing pharmaceutical compositions for treating mammals |
| 03/21/2001 | EP1084242A2 Phagocytic assay method |
| 03/21/2001 | EP1084234A2 Human deadenylating nuclease, its production and its use |
| 03/21/2001 | EP1084147A1 Process for producing immunoglobulins for intravenous administration and other immunoglobulin products |
| 03/21/2001 | EP1084146A2 Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof |
| 03/21/2001 | EP1084145A2 Antibodies to the ed-b domain of fibronectin, conjugates containing them and use thereof for diagnosis and therapy of tumors and diseases associated with angiogenesis |
| 03/21/2001 | EP1084135A1 The human kidney specific gene kk86 |
| 03/21/2001 | EP1083928A1 Method of inhibiting angiogenesis and tumor growth and preventing tumor growth and metastases |
| 03/21/2001 | EP1083927A1 HUMAN MINOR VAULT PROTEIN p193 |
| 03/21/2001 | EP1083925A1 Acrosomal sperm protein and uses thereof |
| 03/21/2001 | EP1083920A1 Novel antibacterial compounds |
| 03/21/2001 | EP1083919A1 Novel antiviral compounds |
| 03/21/2001 | EP1083918A1 Novel therapeutic agents that modulate 5-ht receptors |
| 03/21/2001 | EP1083909A1 hCEPR RECEPTOR |
| 03/21/2001 | EP1083883A1 Stabilizers for lyophilized vaccines |
| 03/21/2001 | EP0833662B1 A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate |
| 03/21/2001 | EP0734529B1 Methods and materials for the detection of staphylococcus aureus |
| 03/21/2001 | CN1288469A Monoclonal antibody anti alpha; V-integrin and it use to inhibit & alpha; V & beta; 6-integrain attachment to fibronectine |
| 03/21/2001 | CN1288468A Antibodies against human IL-12 |
| 03/21/2001 | CN1288384A Lipooligosaccharide-based vaccine for prevention of i(moraxella) i(branhamella) i (catarrhalis) infections in mammals |
| 03/21/2001 | CN1063343C Hepatitis B surface antigen protein having ammonia end with pre-surface antigen determinant |
| 03/20/2001 | US6204371 Compositions and methods for the treatment and diagnosis of immune disorders |
| 03/20/2001 | US6204370 MN gene and protein |